<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03443024</url>
  </required_header>
  <id_info>
    <org_study_id>DRM06-AD01</org_study_id>
    <nct_id>NCT03443024</nct_id>
  </id_info>
  <brief_title>A Study of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis</brief_title>
  <official_title>A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dermira, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dermira, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the safety and efficacy of lebrikizumab compared
      with placebo in patients with moderate-to-severe atopic dermatitis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 30, 2018</start_date>
  <completion_date type="Anticipated">May 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent change in Eczema Area and Severity Index (EASI) from baseline to Week 16.</measure>
    <time_frame>Week 16</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with a 75% improvement from baseline in EASI (EASI75) at Week 16.</measure>
    <time_frame>Week 16</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patient with an IGA score of 0 (clear) or 1 (almost clear) and a reduction ≥2 points from baseline to Week 16 (5-point scale).</measure>
    <time_frame>Week 16</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with EASI &lt;7 at Week 16.</measure>
    <time_frame>Week 16</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients achieving EASI50 and EASI90 at Week 16.</measure>
    <time_frame>Week 16</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent change in the sleep loss numerical rating scale (NRS) score from baseline to Week 16.</measure>
    <time_frame>Week 16</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent change in pruritus NRS score from baseline to Week 16.</measure>
    <time_frame>Week 16</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with pruritus NRS change of ≥3 from baseline to Week 16.</measure>
    <time_frame>Week 16</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with pruritus NRS change of ≥4 from baseline to Week 16.</measure>
    <time_frame>Week 16</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Body Surface Area (BSA) involved with AD from baseline to Week 16.</measure>
    <time_frame>Week 15</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Atopic Dermatitis Impact Questionnaire (ADIQ) score.</measure>
    <time_frame>Week 16</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">275</enrollment>
  <condition>Atopic Dermatitis</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lebrikizumab, 125 mg every 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lebrikizumab, 250 mg every 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lebrikizumab, 250 mg every 2 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebos, every 2 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Lebrikizumab</intervention_name>
    <description>Sterile liquid solution injected subcutaneously</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebos</intervention_name>
    <description>Solution injected subcutaneously</description>
    <arm_group_label>Group 4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female, 18 years or older.

          -  Chronic AD as defined by Hanifin and Rajka (1980) that has been present for ≥1 year
             before the screening visit .

          -  Eczema Area and Severity Index (EASI) score ≥16 at the screening and the baseline
             visit.

          -  Investigator Global Assessment (IGA) score ≥3 (scale of 0 to 4) at the screening and
             the baseline visit.

          -  ≥10% body surface area (BSA) of AD involvement at the screening and the baseline
             visit.

        Exclusion Criteria:

          -  Treatment with any of the following agents within 4 weeks prior to the baseline visit:

          -  Immunosuppressive/immunomodulating drugs (e.g., systemic corticosteroids,
             cyclosporine, mycophenolate-mofetil, IFN-γ, Janus kinase inhibitors, azathioprine,
             methotrexate, etc.)

          -  Phototherapy and photochemotherapy (PUVA) for AD.

          -  Treatment with topical corticosteroids (TCS) or topical calcineurin inhibitors (TCI)
             within 1 week prior to the baseline visit.

          -  Treatment with:

          -  An investigational drug within 8 weeks or within 5 half-lives (if known), whichever is
             longer, prior to the baseline visit.

          -  Dupilumab within 3 months prior to baseline visit.

          -  Cell-depleting biologics, including rituximab, within 6 months prior to the baseline
             visit.

          -  Other biologics within 5 half-lives (if known) or 16 weeks prior to baseline visit
             (whichever is longer).

          -  Use of prescription moisturizers within 7 days of the baseline visit.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kathy Hormel</last_name>
    <phone>831-234-4905</phone>
    <email>kathy.hormel@dermira.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clear Dermatology &amp; Aesthetics Center</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85255</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jenna Sanford</last_name>
      <phone>480-398-1550</phone>
      <email>jenna.cleardermatology@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Brenda LaTowsky, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dermatology Trial Associates</name>
      <address>
        <city>Bryant</city>
        <state>Arkansas</state>
        <zip>72022</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Makenzie Mixon</last_name>
      <phone>501-655-6138</phone>
      <email>mmixon@burkepharmaceutical.com</email>
    </contact>
    <investigator>
      <last_name>Dowling Stough, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwest Arkansas Clinical Trials Center</name>
      <address>
        <city>Rogers</city>
        <state>Arkansas</state>
        <zip>72758</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Filmer</last_name>
      <phone>479-876-8205</phone>
    </contact>
    <investigator>
      <last_name>Cheryl Hull, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Dermatology Clinical Research, Inc.</name>
      <address>
        <city>Fremont</city>
        <state>California</state>
        <zip>94538</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Natalia Cobian</last_name>
      <phone>510-797-0140</phone>
      <email>nataliac@ctr4derm.com</email>
    </contact>
    <investigator>
      <last_name>Sunil Dhawan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Southern California</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cesar Rivas-Sanchez</last_name>
      <phone>323-865-3641</phone>
      <email>rivassan@usc.edu</email>
    </contact>
    <investigator>
      <last_name>April Armstrong, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dermatology Research Associates</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dasmany Deniz</last_name>
      <phone>310-337-7171</phone>
      <email>ddeniz@drsofen.com</email>
    </contact>
    <investigator>
      <last_name>Howard Sofen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Dermatology and Laser Surgery</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95819</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Anderson</last_name>
      <phone>916-454-5922</phone>
      <email>susan@dermatoloyandlasersurgery.com</email>
    </contact>
    <investigator>
      <last_name>Emil Tangetti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>TCR Medical Corporation</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mary Ahmadyar</last_name>
      <phone>858-571-6800</phone>
      <email>mahmadyar@therapeuticsresearch.com</email>
    </contact>
    <investigator>
      <last_name>Neal Bhatia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Science Institute</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria Giles</last_name>
      <phone>310-828-8887</phone>
      <email>mgiles@csird.com</email>
    </contact>
    <investigator>
      <last_name>Paul Steven Yamauchi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>George Washington Medical Faculty Associates</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20037</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Rengifo Pardo</last_name>
      <phone>202-741-3547</phone>
      <email>mrengiforpardo@mfa.gwu.edu</email>
    </contact>
    <investigator>
      <last_name>Alison Ehrlich, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Total Vein and Skin</name>
      <address>
        <city>Boynton Beach</city>
        <state>Florida</state>
        <zip>33437</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dori Dennett</last_name>
      <phone>561-739-5252</phone>
    </contact>
    <investigator>
      <last_name>Joshua Berlin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Florida Academic Centers Research and Education, LLC</name>
      <address>
        <city>Coral Gables</city>
        <state>Florida</state>
        <zip>33134</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lys Robles</last_name>
      <phone>305-624-2110</phone>
      <phone_ext>211</phone_ext>
      <email>lrobles@fadcenter.com</email>
    </contact>
    <investigator>
      <last_name>Francisco Kerdel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Olympian Clinical Research</name>
      <address>
        <city>Largo</city>
        <state>Florida</state>
        <zip>33770</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dustin Siegert</last_name>
      <phone>727-935-0508</phone>
      <email>dsiegert@olympianresearch.com</email>
    </contact>
    <investigator>
      <last_name>Matthew Zook, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tory Sullivan, MD PA</name>
      <address>
        <city>North Miami Beach</city>
        <state>Florida</state>
        <zip>33162</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Choockley</last_name>
      <phone>305-652-8600</phone>
      <email>anna@sullivandermatology.com</email>
    </contact>
    <investigator>
      <last_name>Tory Sullivan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>International Clinical Research - US, LLC</name>
      <address>
        <city>Sanford</city>
        <state>Florida</state>
        <zip>32771</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Ragan</last_name>
      <phone>407-878-5830</phone>
      <email>aragan@icresearch.net</email>
    </contact>
    <investigator>
      <last_name>Rion Forconi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Integrated Clinical Research, LLC</name>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <zip>33406</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Iparraguirre</last_name>
      <phone>561-964-6664</phone>
      <email>ciparraguirre@icrfl.com</email>
    </contact>
    <investigator>
      <last_name>Barry Kuttner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Marietta Dermatology Clinical Research, Inc.</name>
      <address>
        <city>Marietta</city>
        <state>Georgia</state>
        <zip>30060</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>April Brown</last_name>
      <phone>770-422-1013</phone>
      <email>abrown@mdcrinc.com</email>
    </contact>
    <investigator>
      <last_name>Mark Knautz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Advanced Medical Research, PC</name>
      <address>
        <city>Sandy Springs</city>
        <state>Georgia</state>
        <zip>30328</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daria Ustinova</last_name>
      <phone>404-939-9220</phone>
      <email>dustinova@atlmedderm.com</email>
    </contact>
    <investigator>
      <last_name>Jamie Weisman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dundee Dermatology</name>
      <address>
        <city>West Dundee</city>
        <state>Illinois</state>
        <zip>60118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JoAnn Hawkinson</last_name>
      <phone>847-851-8888</phone>
      <email>joannchawkinson@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Paul Getz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dawes Fretzin Clinical Research Group, LLC</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46256</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kara Jones</last_name>
      <phone>317-516-5030</phone>
      <email>kjones4@ecommunity.com</email>
    </contact>
    <investigator>
      <last_name>Scott Fretzin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Indiana Clinical Trials Center</name>
      <address>
        <city>Plainfield</city>
        <state>Indiana</state>
        <zip>46168</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Rice</last_name>
      <phone>317-837-6082</phone>
      <email>arice@indianatrials.com</email>
    </contact>
    <investigator>
      <last_name>Scott Guenthner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kansas City Dermatology, PA</name>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shelby Williams</last_name>
      <phone>913-541-3230</phone>
      <email>swilliams@kcderm.com</email>
    </contact>
    <investigator>
      <last_name>Mark McCune, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Skin Sciences, PLLC</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40217</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Stewart</last_name>
      <phone>502-451-9000</phone>
    </contact>
    <investigator>
      <last_name>Leon Kircik, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Meridian Clinical Research, LLC</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Thomassie</last_name>
      <phone>225-768-2850</phone>
      <email>athomassie@mcrmed.com</email>
    </contact>
    <investigator>
      <last_name>Tom Meek Jr, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dermatology and Skin Cancer Specialists, LLC</name>
      <address>
        <city>Rockville</city>
        <state>Maryland</state>
        <zip>20850</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Blondo</last_name>
      <phone>301-355-3183</phone>
      <email>tblondo@usdermpartners.com</email>
    </contact>
    <investigator>
      <last_name>Benjamin Lockshin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ActivMed Practices &amp; Research, Inc.</name>
      <address>
        <city>Beverly</city>
        <state>Massachusetts</state>
        <zip>01915</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonida Dake</last_name>
      <phone>978-969-6897</phone>
      <email>jdake@activmedresearch.com</email>
    </contact>
    <investigator>
      <last_name>David Greenstein, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Somerset Skin Centre</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48084</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dianna Fortunato</last_name>
      <phone>248-244-8448</phone>
      <email>dianna@somersetskincentre.com</email>
    </contact>
    <investigator>
      <last_name>George Murakawa, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>JDR Dermatology Research</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89148</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kathy Gilbert</last_name>
      <phone>702-331-4123</phone>
      <email>kg.drdr@gmail.com</email>
    </contact>
    <investigator>
      <last_name>James Del Rosso, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ActivMed Practices &amp; Research, Inc.</name>
      <address>
        <city>Portsmouth</city>
        <state>New Hampshire</state>
        <zip>03801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Young</last_name>
      <phone>603-319-8863</phone>
      <email>pyoung@acivmedresearch.com</email>
    </contact>
    <investigator>
      <last_name>Abel Jarell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Academic Dermatology Associates</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Escudero</last_name>
      <phone>505-247-4220</phone>
      <email>vescudero@abqdermtrials.com</email>
    </contact>
    <investigator>
      <last_name>Eduardo Tschen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Schweiger Dermatology, PLLC</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10022</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Tropeano</last_name>
      <phone>646-604-4344</phone>
      <email>mtropeano@schweigerderm.com</email>
    </contact>
    <investigator>
      <last_name>Jeremy Fenton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marjorie Pernia</last_name>
      <phone>212-241-3288</phone>
      <email>marjorie.pernia@mssm.edu</email>
    </contact>
    <investigator>
      <last_name>Emma Guttman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sadick Research Group, LLC.</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10075</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monica Serra</last_name>
      <phone>212-772-7242</phone>
      <email>mserra@sadickdermatology.com</email>
    </contact>
    <investigator>
      <last_name>Neil Sadick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Piedmont Plastic Surgery and Dermatology</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28277</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dion Morrison</last_name>
      <phone>704-527-6672</phone>
      <email>dion.morrison@pmg-research.com</email>
    </contact>
    <investigator>
      <last_name>Patrick McElgunn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Research Associates, LLC</name>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruby Lancaster</last_name>
      <phone>919-781-2514</phone>
      <email>rlancaster@wakeresearch.com</email>
    </contact>
    <investigator>
      <last_name>Adnan Nasir, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wilmington Dermatology Center</name>
      <address>
        <city>Wilmington</city>
        <state>North Carolina</state>
        <zip>28405</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maryann Ball</last_name>
      <phone>910-256-4350</phone>
      <email>mball@wilmingtondermatologycenter.com</email>
    </contact>
    <investigator>
      <last_name>Rosalyn George, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospitals Cleveland Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christina Bona</last_name>
      <phone>216-844-8200</phone>
      <email>Christina.Bona@UHhospitals.org</email>
    </contact>
    <investigator>
      <last_name>Neil Korman, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lynn Health Science Institute</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lacey Dietz</last_name>
      <phone>405-602-3939</phone>
      <email>ldietz@lhsi.net</email>
    </contact>
    <investigator>
      <last_name>Raymond Cornelison, Jr., MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Medical Research Center</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97223</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Logan</last_name>
      <phone>503-245-1525</phone>
      <email>JLogan@oregonmedicalresearch.com</email>
    </contact>
    <investigator>
      <last_name>Andrew Blauvelt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Partners, LLC</name>
      <address>
        <city>Johnston</city>
        <state>Rhode Island</state>
        <zip>02919</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Caroline DiGiulio</last_name>
      <phone>401-454-3800</phone>
      <email>clinicalpartnersllc@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Ellen Frankel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Research Center of the Carolinas</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29407</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Linda Wozniak</last_name>
      <phone>843-556-8886</phone>
      <email>linda@dermandlaser.com</email>
    </contact>
    <investigator>
      <last_name>Todd Schlesinger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rivergate Dermatology Clinical Research Center</name>
      <address>
        <city>Goodlettsville</city>
        <state>Tennessee</state>
        <zip>37072</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda Spear</last_name>
      <phone>615-859-7546</phone>
      <email>aspear@rivderm.com</email>
    </contact>
    <investigator>
      <last_name>Keith Loven, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>International Clinical Research - Tennessee LLC</name>
      <address>
        <city>Murfreesboro</city>
        <state>Tennessee</state>
        <zip>37130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jamie Lokey</last_name>
      <phone>615-410-3460</phone>
      <email>jlokey@icresearch.net</email>
    </contact>
    <investigator>
      <last_name>Christina Feser, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tennessee Clinical Research Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brynne Thompson</last_name>
      <phone>615-383-9668</phone>
      <email>bthompson@tnclinicalresearch.com</email>
    </contact>
    <investigator>
      <last_name>Michael Gold, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arlington Research Center, Inc.</name>
      <address>
        <city>Arlington</city>
        <state>Texas</state>
        <zip>76011</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elvia Mares</last_name>
      <phone>817-795-7546</phone>
      <email>elviam@acderm.com</email>
    </contact>
    <investigator>
      <last_name>Angela Moore, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Westlake Dermatology Clinical Research Center</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78746</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luke Gutierrez</last_name>
      <phone>512-615-3193</phone>
      <email>lukeg@westlakedermatology.com</email>
    </contact>
    <investigator>
      <last_name>Daniel Friedmann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bellaire Dermatology Associates</name>
      <address>
        <city>Bellaire</city>
        <state>Texas</state>
        <zip>77401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Harmony Saqr</last_name>
      <phone>832-553-2339</phone>
      <email>hsaqr@bda-derm.com</email>
    </contact>
    <investigator>
      <last_name>Craig Teller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Menter Dermatology Research</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75246</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xochitl Flores</last_name>
      <phone>972-354-7989</phone>
      <email>xflores@menterderm.com</email>
    </contact>
    <investigator>
      <last_name>Alan Menter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Progressive Clinical Research, PA</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Tench</last_name>
      <phone>210-614-5557</phone>
      <email>ktench@progclin.com</email>
    </contact>
    <investigator>
      <last_name>Mark Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Clinical Studies, LTD. LLP</name>
      <address>
        <city>Webster</city>
        <state>Texas</state>
        <zip>77598</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Barnella</last_name>
      <phone>281-333-2288</phone>
      <email>cbarnella@ccstexas.com</email>
    </contact>
    <investigator>
      <last_name>Stephen Tyring, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dermatology Research Center, Inc.</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84117</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine Pyne</last_name>
      <phone>801-269-0135</phone>
      <email>Christine@dermatologyresearch.net</email>
    </contact>
    <investigator>
      <last_name>Leonard Swinyer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Virginia Clinical Research, Inc.</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tina Watkins</last_name>
      <phone>757-625-0151</phone>
      <email>twatkins@vcrinc.org</email>
    </contact>
    <investigator>
      <last_name>David Pariser, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dermatology Associates of Seattle</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tosha White</last_name>
      <phone>206-267-2100</phone>
      <email>twhite@daseattle.com</email>
    </contact>
    <investigator>
      <last_name>Peter Jenkin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Premier Clinical Research</name>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Ryckman</last_name>
      <phone>509-343-3710</phone>
      <email>ERyckman@premierclinicalresearch.com</email>
    </contact>
    <investigator>
      <last_name>William Werschler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 16, 2018</study_first_submitted>
  <study_first_submitted_qc>February 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 22, 2018</study_first_posted>
  <last_update_submitted>May 21, 2018</last_update_submitted>
  <last_update_submitted_qc>May 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Eczema</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Dermatitis, Atopic</mesh_term>
    <mesh_term>Eczema</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antibodies, Monoclonal</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

